About the Company
We do not have any company description for Alpha Cognition Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Alpha Cognition Inc.
Alpha Cognition Inc. (ACOG) Reports Q2 Loss, Tops Revenue Estimates
Alpha Cognition Inc. (ACOG) came out with a quarterly loss of $0.65 per share versus the Zacks Consensus Estimate of a loss ...
Alpha Cognition Inc. Reports Second Quarter 2025 Financial Results and Provides Operational Update
VANCOUVER, British Columbia & GRAPEVINE, Texas, August 14, 2025--Alpha Cognition Inc. (Nasdaq: ACOG) ("Alpha Cognition" or ...
Alpha Cognition Inc. Common Stock (NASDAQ:ACOG) Q2 2025 Earnings Call Transcript
August 14, 2025Alpha Cognition Inc. Common Stock misses on earnings expectations. Reported EPS is $-0.65 EPS, expectations were $-0.46. Operator: Greetings, and welcome to the Alpha Cognition Earnings ...
Alpha Cognition, Inc. Announces Participation in the D. Boral Capital ...
Grapevine, Texas-- (Newsfile Corp. - April 30, 2025) - Alpha Cognition, Inc. (NASDAQ: ACOG), today announced its participation in the D. Boral Capital Inaugural Global Conference, taking place May ...
Alpha Cognition, Inc. On Track to Secure Financing for Continued Growth
Alpha Cognition Inc. is a commercial development stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s ...
Alpha Cognition to Report Second Quarter 2025 Financial Results and ...
Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and ...
Alpha Cognition Inc. Reports Strong Q2 2025 Results
Alpha Cognition Inc ( ($ACOG) ) has released its Q2 earnings. Here is a breakdown of the information Alpha Cognition Inc presented to its ...
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q2 2025
Alpha Cognition Inc. (NASDAQ: ACOG): Stonegate Capital Partners updates their coverage on Alpha Cognition Inc. (NASDAQ: ACOG) ...
Alpha Cognition Announces Voluntary Delisting from CSE
Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and ...
Alpha Cognition Announces Positive Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain Injury
Detailed price information for Alpha Cognition Inc (ACOG-Q) from The Globe and Mail including charting and trades.
Alpha Cognition Announces Change of Officer
VANCOUVER, British Columbia--(BUSINESS WIRE)-- Alpha Cognition Inc. (ACOG:CA) (OTCQB: ACOGF) (“Alpha Cognition” or the “Company”), a biopharmaceutical company committed to developing novel ...
Alpha Cognition to Report Second Quarter 2025 Financial Results and Operating Overview
Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative ...
Similar Companies
Loading the latest forecasts...